z-logo
open-access-imgOpen Access
Excessive Autophagy Contributes to Neuron Death in Cerebral Ischemia
Author(s) -
Shi Ruoyang,
Weng Jiequn,
Zhao Ling,
Li XinMin,
Gao TianMing,
Kong Jiming
Publication year - 2012
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/j.1755-5949.2012.00295.x
Subject(s) - autophagy , becn1 , programmed cell death , microbiology and biotechnology , ischemia , immunocytochemistry , western blot , hypoxia (environmental) , viability assay , neuron , biology , chemistry , cell , apoptosis , neuroscience , medicine , endocrinology , biochemistry , oxygen , gene , organic chemistry
SUMMARY Aims: To determine the extent to which autophagy contributes to neuronal death in cerebral hypoxia and ischemia. Methods: We performed immunocytochemistry, western blot, cell viability assay, and electron microscopy to analyze autophagy activities in vitro and in vivo. Results: In both primary cortical neurons and SH‐SY5Y cells exposed to oxygen and glucose deprivation (OGD)for 6 h and reperfusion (RP) for 24, 48, and 72 h, respectively, an increase of autophagy was observed as determined by the increased ratio of LC3‐II to LC3‐I and Beclin‐1 (BECN1) expression. Using Fluoro‐Jade C and monodansylcadaverine double‐staining, and electron microscopy we found the increment in autophagy after OGD/RP was accompanied by increased autophagic cell death, and this increased cell death was inhibited by the specific autophagy inhibitor, 3‐methyladenine. The presence of large autolysosomes and numerous autophagosomes in cortical neurons were confirmed by electron microscopy. Autophagy activities were increased dramatically in the ischemic brains 3–7 days postinjury from a rat model of neonatal cerebral hypoxia/ischemia as shown by increased punctate LC3 staining and BECN1 expression. Conclusion: Excessive activation of autophagy contributes to neuronal death in cerebral ischemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here